Insider Selling: Merge Healthcare COO Sells 15,000 Shares of Stock (MRGE)
Merge Healthcare (NASDAQ:MRGE) COO Nancy J. Koenig unloaded 15,000 shares of the stock in a transaction dated Tuesday, June 3rd. The shares were sold at an average price of $2.14, for a total transaction of $32,100.00. Following the completion of the transaction, the chief operating officer now directly owns 350,000 shares of the company’s stock, valued at approximately $749,000. The transaction was disclosed in a filing with the SEC, which is available at this link.
Shares of Merge Healthcare (NASDAQ:MRGE) traded down 2.29% during mid-day trading on Tuesday, hitting $2.13. 295,038 shares of the company’s stock traded hands. Merge Healthcare has a one year low of $1.97 and a one year high of $4.71. The stock has a 50-day moving average of $2.25 and a 200-day moving average of $2.32. The company’s market cap is $201.7 million.
Merge Healthcare (NASDAQ:MRGE) last issued its quarterly earnings data on Wednesday, April 30th. The company reported $0.04 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.04. The company had revenue of $50.90 million for the quarter, compared to the consensus estimate of $52.49 million. During the same quarter in the previous year, the company posted ($0.01) earnings per share. The company’s revenue for the quarter was down 20.0% on a year-over-year basis. Analysts expect that Merge Healthcare will post $0.10 EPS for the current fiscal year.
Separately, analysts at Zacks downgraded shares of Merge Healthcare from a “neutral” rating to an “underperform” rating in a research note on Monday, March 24th. They now have a $2.25 price target on the stock.
Merge Healthcare Incorporated (NASDAQ:MRGE) develops software solutions that facilitate the sharing of images to create an electronic healthcare experience for patients and physicians.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.